Revenue YoY
+6.59%
Operating Income YoY
+14.20%
Net Income YoY
-53.50%
Net Margin Δ
-1799 bps
Net income bridge for Abbott Laboratories (ABT) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: −$7.23B-53.50%
Profit bridge breakdown for Abbott Laboratories (ABT) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $13.50B | — |
| Revenue | $2.79B | +38.6% |
| Cost of Revenue | $883.00M | +12.2% |
| Operating Expenses | −$2.65B | -36.7% |
| Other Income / Expense | −$238.00M | -3.3% |
| Income Tax | −$8.01B | -110.8% |
| Net Income | $6.28B | — |
- Prior Net Income$13.50B
- Revenue$2.79B
- Cost of Revenue$883.00M
- Operating Expenses−$2.65B
- Other Income / Expense−$238.00M
- Income Tax−$8.01B
- Net Income$6.28B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement